Clinically significant pharmacokinetic drug interactions with benzodiazepines

@article{Tanaka1999ClinicallySP,
  title={Clinically significant pharmacokinetic drug interactions with benzodiazepines},
  author={E. Tanaka},
  journal={Journal of Clinical Pharmacy and Therapeutics},
  year={1999},
  volume={24}
}
  • E. Tanaka
  • Published 1999
  • Chemistry, Medicine
  • Journal of Clinical Pharmacy and Therapeutics
The reports of interactions between benzodiazepines (BZPs) and other drugs (e.g. antidepressants, selective serotonin reuptake inhibitors, antiulcer drugs, antiepileptic drugs, macrolide antibiotics) during their combined use are reviewed. In general, metabolism of BZPs is delayed when combined with a number of other drugs but some reports have suggested otherwise. 
Clinically significant pharmacokinetic drug interactions with psychoactive drugs: antidepressants and antipsychotics and the cytochrome P450 system
TLDR
It is useful to phenotype CYP1C19 and CYP2D6 (extensive metabolizers or poor metabolizers) before giving psychotherapeutic drugs whose metabolism might be inhibited by other drugs. Expand
Benzodiazepines in epilepsy: pharmacology and pharmacokinetics
TLDR
Among these BZDs, clorazepate has a unique profile that includes a long half‐life of its active metabolite and slow onset of tolerance, which could theoretically help minimize adverse events. Expand
Herbal Pharmacokinetics : A Practitioner Update With Reference to St . John ' s Wort ( Hypericum perforatum ) Herb-Drug Interactions
Pharmacokinetic data is important for understanding interactions between herbs and pharmaceuticals. Pharmacokinetic information about herbal remedies is not widely available due to several factorsExpand
Herbal Pharmacokinetics : A Practitioner Update With Reference to St . John ’ s Wort ( Hypericum perforatum )
Why Pharmacokinetics? Herbalists have long studied the effect of herbal medicines on the body, but have hitherto paid less attention to the effects of the body on herbal medicines. This dichotomyExpand
Clinically Significant Psychotropic Drug-Drug Interactions in the Primary Care Setting
TLDR
Increased awareness of clinically relevant psychotropic drug interactions can aid clinicians to achieve optimal therapeutic outcomes in patients in the primary care setting. Expand
Concomitant use of policosanol and benzodiazepines in older patients
TLDR
Policosanol is a cholesterol-lowering drug well tolerated in different populations, including those with high consumption of concomitant drugs, and the frequency of adverse events (AE) has been very low, suggesting a low risk of adverse drug interactions. Expand
Clinically important drug–drug interactions in primary care
TLDR
An investigation of potentially serious DDIs, using a university primary care–based system capturing prescription records from its primary care services, is reported on. Expand
Lack of Pharmacokinetic Interactions Between Steady-State Zonisamide and Valproic Acid in Patients with Epilepsy
TLDR
There is no apparent clinically significant effect of steady-state dosing of zonisamide on valproic acid pharmacokinetics, and valprooic acid did not appear to affect the pharmacokinetic ofZonisamide, indicating that no dosage adjustment of either drug should be required when they are used in combination in patients with epilepsy. Expand
Drug Bioactivation Covalent Binding to Target Proteins and Toxicity Relevance
A number of therapeutic drugs with different structures and mechanisms of action have been reported to undergo metabolic activation by Phase I or Phase II drug-metabolizing enzymes. The bioactivationExpand
Toxicological Significance of Mechanism-Based Inactivation of Cytochrome P450 Enzymes by Drugs
TLDR
The fate of P450s after the inactivation and the toxicological consequences remains to be elucidated, while it has been suggested that P 450s modified and degraded are involved in some forms of tissue toxicity. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 177 REFERENCES
Pharmacokinetic interactions between acute alcohol ingestion and single doses of benzodiazepines, and tricyclic and tetracyclic antidepressants – an update
Recent reports of interactions between alcohol and benzodiazepines, tricyclic and tetracyclic antidepressants during their acute concomitant use are reviewed. Acute ingestion of alcohol (ethanol)Expand
Selective Serotonin Reuptake Inhibitors and CNS Drug Interactions
TLDR
In vitro and in vivo evidence for drug interactions between SSRIs and other central nervous system drugs is reviewed, with special emphasis on antipsychotics, tricyclic anti-depressants and benzodiazepines. Expand
[Drug interactions of midazolam].
TLDR
In vitro screening factors that could interfere with the rate of midazolam biotransformation (drug-drug interactions) were investigated andabolite production (1'-and 4-OH-midazol am) was monitored in human liver microsomes. Expand
Serotonin selective reuptake inhibitor drug interactions and the cytochrome P450 system.
The article focuses on the effects of the serotonin selective reuptake inhibitors (SSRIs) on specific drug metabolizing isoenzymes: CYP2D6, CYP3A3/4, CYP1A2, CYP2C9, and CYP2C19. Both in vitro and inExpand
Pharmacokinetic Drug Interactions with Anti-Ulcer Drugs
  • R. Negro
  • Medicine
  • Clinical pharmacokinetics
  • 1998
TLDR
This article reviews pharmacokinetic interactions with anti-ulcer drugs, paying particular attention to those which have clinically relevant adverse effects. Expand
Drug interactions with azithromycin and the macrolides: an overview.
  • M. Nahata
  • Medicine
  • The Journal of antimicrobial chemotherapy
  • 1996
TLDR
There is no evidence that azithromycin, unlike most other macrolides, interacts with any of these agents to produce clinically significant adverse effects, and the explanation for this variation appears to be azathromycin's inability to induce and bind to the cytochrome P450 IIIA enzyme system. Expand
Drug Interactions with Proton Pump Inhibitors
TLDR
A synergy has been confirmed between omeprazole and amoxicillin or clarithromycin in the antibacterial effect against Helicobacter pylori and the small proportion of slow metabolisers is at no additional risk for clinically important drug interactions. Expand
Update: Clinically Significant Cytochrome P‐450 Drug Interactions
TLDR
Of the more than 30 human isoenzymes identified to date, the major ones responsible for drug metabolism include CYP3A4, CYP1A2, and the CYP2C subfamily. Expand
Clinically important pharmacokinetic drug–drug interactions: role of cytochrome P450 enzymes
  • E. Tanaka
  • Biology, Medicine
  • Journal of clinical pharmacy and therapeutics
  • 1998
TLDR
Understanding the mechanisms of enzyme inhibition or induction is extremely important in order to give appropriate multiple‐drug therapies and in the future, it may help to identify individuals at greatest risk of drug interactions and adverse events. Expand
Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole
TLDR
Ketoconazole and itraconazole may seriously interact with some of the substrates of CYP3A4 (e.g., terfenadine) and their possible interaction with triazolam in humans is important to uncover. Expand
...
1
2
3
4
5
...